Companies / EVE

EVE HEALTH GROUP LIMITED.

ASX:EVEFinancial ServicesSuspended from quotation
352.3M shares on issueASX (delayed) · as of 28 July 2026$0.017price · delayed$6.0Mmarket cap · indicative
NR
Dilution grade

Not rated — the company is suspended from quotation

Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangomitted — option-line data cannot be adjusted for the share consolidation on record in the last 24 months
In-the-money supplyomitted — option-line data cannot be adjusted for the share consolidation on record in the last 24 months
Pending proposed issuesnone

EVE HEALTH GROUP LIMITED.'s ordinary share count was 352M as of May 2026. The company completed six capital raises in the past 24 months for total disclosed proceeds of A$4.4M, most recently raising A$1.3M in March 2026. Options and rights overhang is omitted because outstanding option-line data cannot be adjusted for the recent share consolidation. At the March 2026 quarter the company reported A$1.3M in available cash. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
—
Max option dilution · omitted
—
ITM option dilution
2
Raises · last 12 months
3.4 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 352.3M per ASX (delayed) (28 July 2026).
267.8M298.8M329.9MJune 25Jan 26July 26Cash raise · 10 Mar 2026Cash raise · 6 Oct 2025

Cash runway

3.4 qtrs
Two to four quarters of funding at the recent spend rate.
$1.3M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 July 20263H · cancellationEVE : ORDINARY FULLY PAID352.3MAppendix 3H
19 June 20263H · cancellationEVE : ORDINARY FULLY PAID352.3MAppendix 3H
8 May 20262A · quoted issueEVE : ORDINARY FULLY PAID352.3MAppendix 2A
8 May 20263G · unquotedEVE : ORDINARY FULLY PAID349.6MAppendix 3G
22 Mar 20262A · quoted issueEVE : ORDINARY FULLY PAID349.6MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

6 cash raises in the last 24 months · 2 in the last 12 months

$1.3M
Capital raise
10 Mar 2026
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

Options summary omitted. option-line data cannot be adjusted for the share consolidation on record in the last 24 months

Director dealings

DateDirectorTypeSharesOptionsValueSource
30 June 2026Gregory William FrySell2.1M150k—3Y notice
30 June 2026Stuart GunzburgSell18.5M2.0M—3Y notice
21 May 2026Gregory William FryOther850k150k$18k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

1 July 2026Change of Director's Interest Notice x 3
1 July 2026Notification of cessation of securities - EVE
19 June 2026Notification of cessation of securities - EVE
15 June 2026$PEve Initiates Pilot Clinical Study for Libbo ED Film
4 June 2026Release of Securities from Escrow
22 May 2026Change of Director's Interest Notice
8 May 2026Notification regarding unquoted securities - EVE
8 May 2026Change of Director's Interest Notice
8 May 2026Application for quotation of securities - EVE
8 May 2026Results of Meeting
28 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
28 Apr 2026Change in substantial holding
27 Apr 2026$PAppointment of Chief Executive Officer
20 Apr 2026Change in substantial holding
19 Apr 2026Change in substantial holding
8 Apr 2026Change in substantial holding
7 Apr 2026Notice of General Meeting/Proxy Form
25 Mar 2026$PInvestor Presentation
25 Mar 2026Change in substantial holding
22 Mar 2026Becoming a substantial holder

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.